Sona Nanotech Inc. (SNANF)
USD 0.18
(0.0%)
USD 0.18
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -2.6 Million CAD | -5.92% |
| 2022 | -2.67 Million CAD | 74.12% |
| 2021 | -10.35 Million CAD | -65.62% |
| 2020 | -6.24 Million CAD | -327.5% |
| 2019 | -1.46 Million CAD | 71.45% |
| 2018 | -5.12 Million CAD | -1331.47% |
| 2017 | -357.72 Thousand CAD | 29.88% |
| 2016 | -510.14 Thousand CAD | 43.8% |
| 2015 | -907.74 Thousand CAD | -80.76% |
| 2014 | -502.17 Thousand CAD | 19.6% |
| 2013 | -624.61 Thousand CAD | 34.56% |
| 2012 | -954.54 Thousand CAD | -9.86% |
| 2011 | -868.84 Thousand CAD | -13.09% |
| 2010 | -768.25 Thousand CAD | 91.16% |
| 2009 | -8.69 Million CAD | -249.68% |
| 2008 | -2.48 Million CAD | -138.67% |
| 2007 | -1.04 Million CAD | -313.99% |
| 2006 | -251.51 Thousand CAD | -6998.98% |
| 2005 | -3543.00 CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -747.76 Thousand CAD | 21.33% |
| 2024 Q2 | -778.86 Thousand CAD | -4.16% |
| 2024 Q3 | -708.64 Thousand CAD | 8.63% |
| 2023 FY | -2.83 Million CAD | -5.92% |
| 2023 Q3 | -858.35 Thousand CAD | -70.54% |
| 2023 Q2 | -503.32 Thousand CAD | -34.36% |
| 2023 Q4 | -950.53 Thousand CAD | -10.74% |
| 2023 Q1 | -374.61 Thousand CAD | -139.61% |
| 2022 Q3 | -785.16 Thousand CAD | 40.86% |
| 2022 Q1 | -1.51 Million CAD | -14.3% |
| 2022 Q4 | 945.84 Thousand CAD | 220.47% |
| 2022 Q2 | -1.32 Million CAD | 12.16% |
| 2022 FY | -2.67 Million CAD | 74.12% |
| 2021 FY | -10.35 Million CAD | -65.62% |
| 2021 Q1 | -3.73 Million CAD | -9.87% |
| 2021 Q2 | -3.14 Million CAD | 15.81% |
| 2021 Q3 | -2.15 Million CAD | 31.33% |
| 2021 Q4 | -1.32 Million CAD | 38.69% |
| 2020 Q2 | -824.46 Thousand CAD | -168.09% |
| 2020 Q4 | -3.39 Million CAD | -97.14% |
| 2020 FY | -6.24 Million CAD | -327.5% |
| 2020 Q1 | -307.52 Thousand CAD | 12.51% |
| 2020 Q3 | -1.72 Million CAD | -108.91% |
| 2019 Q1 | -307.9 Thousand CAD | 93.42% |
| 2019 Q2 | -400.75 Thousand CAD | -30.16% |
| 2019 Q4 | -351.51 Thousand CAD | 12.52% |
| 2019 FY | -1.46 Million CAD | 71.45% |
| 2019 Q3 | -401.8 Thousand CAD | -0.26% |
| 2018 FY | -5.12 Million CAD | -1331.47% |
| 2018 Q4 | -4.68 Million CAD | -3103.84% |
| 2018 Q3 | -146.14 Thousand CAD | 6.23% |
| 2018 Q2 | -155.86 Thousand CAD | -20.55% |
| 2018 Q1 | -129.29 Thousand CAD | -56.0% |
| 2017 Q3 | -88.64 Thousand CAD | -3.64% |
| 2017 FY | -357.72 Thousand CAD | 29.88% |
| 2017 Q4 | -82.88 Thousand CAD | 6.5% |
| 2017 Q2 | -85.52 Thousand CAD | 14.37% |
| 2017 Q1 | -99.88 Thousand CAD | 31.77% |
| 2016 Q2 | -121.56 Thousand CAD | 7.05% |
| 2016 Q4 | -146.39 Thousand CAD | -31.41% |
| 2016 Q3 | -111.4 Thousand CAD | 8.36% |
| 2016 FY | -510.14 Thousand CAD | 43.8% |
| 2016 Q1 | -130.78 Thousand CAD | 73.4% |
| 2015 Q1 | -127.57 Thousand CAD | 15.96% |
| 2015 Q4 | -491.73 Thousand CAD | -239.19% |
| 2015 Q3 | -144.97 Thousand CAD | -1.06% |
| 2015 Q2 | -143.45 Thousand CAD | -12.44% |
| 2015 FY | -907.74 Thousand CAD | -80.76% |
| 2014 Q4 | -151.8 Thousand CAD | -28.22% |
| 2014 Q1 | -137.27 Thousand CAD | -2.79% |
| 2014 Q2 | -123.7 Thousand CAD | 9.88% |
| 2014 Q3 | -118.39 Thousand CAD | 4.3% |
| 2014 FY | -502.17 Thousand CAD | 19.6% |
| 2013 FY | -624.61 Thousand CAD | 34.56% |
| 2013 Q3 | -164.54 Thousand CAD | 1.96% |
| 2013 Q2 | -167.83 Thousand CAD | -5.76% |
| 2013 Q1 | -158.69 Thousand CAD | -103.76% |
| 2013 Q4 | -133.54 Thousand CAD | 18.84% |
| 2012 Q3 | -168.36 Thousand CAD | 54.1% |
| 2012 Q4 | 4.21 Million CAD | 2605.96% |
| 2012 FY | -954.54 Thousand CAD | -9.86% |
| 2012 Q1 | -4.7 Million CAD | -1965.82% |
| 2012 Q2 | -366.83 Thousand CAD | 92.19% |
| 2011 Q4 | -227.51 Thousand CAD | -2.39% |
| 2011 Q2 | -212.54 Thousand CAD | -2.88% |
| 2011 Q3 | -222.19 Thousand CAD | -4.54% |
| 2011 FY | -868.84 Thousand CAD | -13.09% |
| 2011 Q1 | -206.59 Thousand CAD | -13.46% |
| 2010 Q1 | -208.48 Thousand CAD | 97.42% |
| 2010 FY | -768.25 Thousand CAD | 91.16% |
| 2010 Q3 | -165.82 Thousand CAD | 21.73% |
| 2010 Q4 | -182.08 Thousand CAD | -9.81% |
| 2010 Q2 | -211.86 Thousand CAD | -1.63% |
| 2009 FY | -8.69 Million CAD | -249.68% |
| 2009 Q2 | -222.14 Thousand CAD | 2.29% |
| 2009 Q4 | -8.07 Million CAD | -4815.73% |
| 2009 Q3 | -164.29 Thousand CAD | 26.04% |
| 2009 Q1 | -227.35 Thousand CAD | 63.34% |
| 2008 Q2 | -1.26 Million CAD | -952.52% |
| 2008 FY | -2.48 Million CAD | -138.67% |
| 2008 Q3 | -485.22 Thousand CAD | 61.5% |
| 2008 Q4 | -620.11 Thousand CAD | -27.8% |
| 2008 Q1 | -119.74 Thousand CAD | 73.53% |
| 2007 FY | -1.04 Million CAD | -313.99% |
| 2007 Q1 | -124.97 Thousand CAD | -17.37% |
| 2007 Q4 | -452.4 Thousand CAD | -90.72% |
| 2007 Q3 | -237.21 Thousand CAD | -4.65% |
| 2007 Q2 | -226.66 Thousand CAD | -81.36% |
| 2006 Q2 | -93.35 Thousand CAD | -217009.3% |
| 2006 Q3 | -52.04 Thousand CAD | 44.25% |
| 2006 Q4 | -106.47 Thousand CAD | -104.6% |
| 2006 FY | -251.51 Thousand CAD | -6998.98% |
| 2006 Q1 | -43.00 CAD | 0.0% |
| 2005 FY | -3543.00 CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | -109.901% |
| Arrayit Corporation | -3.62 Million USD | 28.034% |
| Atlantic International Corp. | -5.73 Million USD | 54.523% |
| Biocept, Inc. | -31.98 Million USD | 91.849% |
| Bioqual, Inc. | -19.63 Thousand USD | -13175.13% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | -237.628% |
| DermTech, Inc. | -103.73 Million USD | 97.487% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.105% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 87.484% |
| iMD Companies, Inc. | -175.44 Thousand USD | -1385.91% |
| IDenta Corp. | -1499.00 USD | -173813.943% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 192.973% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 6838.098% |
| InVitro International | -25.33 Thousand USD | -10188.37% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | 63.396% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -4386.113% |
| Medical Imaging Corp. | -819.48 Thousand USD | -218.125% |
| NovelStem International Corp. | -3.52 Million USD | 26.06% |
| Optigenex Inc. | 1.39 Million USD | 287.439% |
| PharmChem, Inc. | 973.14 Thousand USD | 367.891% |
| Proteome Sciences plc | -1.62 Million USD | -60.825% |
| Response Genetics, Inc | -21.37 Million USD | 87.805% |
| Rennova Health, Inc. | -1.4 Million USD | -84.953% |
| RushNet, Inc. | -684.7 Thousand USD | -280.744% |
| ScreenPro Security Inc. | -2.59 Million USD | -0.561% |
| Stella Diagnostics Inc. | -11.42 Million USD | 77.186% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | 66.348% |
| Todos Medical Ltd. | -9.74 Million USD | 73.256% |